Previous studies of ovarian cancer demonstrate a similar effect where increases in MEK phosphorylation are associated with direct phosphorylation of S6-Ribosomal Protein [27], which may result in the inhibition of feedback activation of upstream pathways. Here, MAP2K7 is linked to ovarian cancer.